Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Epidemiol Community Health ; 74(5): 421-427, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32102838

RESUMEN

BACKGROUND: High-sensitivity C reactive protein (hsCRP) has been proposed as a marker of incident cardiovascular disease and vascular mortality, and may also be a marker of non-vascular mortality. However, most evidence comes from either North American or European cohorts. The present proposal aims to investigate the association of hsCRP with the risk of all-cause mortality in a multiethnic Brazilian population. METHODS: Baseline data (2008-2010) of a cohort of 14 238 subjects participating in the Brazilian Longitudinal Study of Adult Health were used. hsCRP was assayed with immunochemistry. The association of baseline covariates with all-cause mortality was calculated by Cox regression for univariate model and adjusted for different confounders after a mean follow-up of 8.0±1.1 years. The final model was adjusted for age, sex, self-rated race/ethnicity, schooling, health behaviours and prevalent chronic disease. RESULTS: The risk of death increased steadily by quartiles of hsCRP, from 1.45 (95% CI 1.05 to 2.01) in quartile 2 to 1.95 (95% CI 1.42 to 2.69) in quartile 4, compared with quartile 1. Furthermore, the persistence of a significant graded association after the exclusion of deaths in the first year of follow-up suggests that these results are unlikely to be due to reverse causality. Finally, the HR was unaffected by the exclusion of participants who had self-reported medical history of diabetes, cancer and chronic obstructive pulmonary disease. CONCLUSIONS: Our study shows that hsCRP level is associated with mortality in a highly admixed population, independent of a large set of lifestyle and clinical variables.


Asunto(s)
Proteína C-Reactiva/análisis , Enfermedades Cardiovasculares/mortalidad , Mortalidad , Neoplasias/mortalidad , Adulto , Anciano , Biomarcadores/sangre , Brasil/epidemiología , Enfermedades Cardiovasculares/sangre , Causas de Muerte , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Neoplasias/sangre , Medición de Riesgo , Factores de Riesgo
2.
Biol Res ; 51(1): 44, 2018 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-30390708

RESUMEN

BACKGROUND: Emerging evidence indicate that miRNAs play an important role on gastric cancer (GC) progression via regulating several downstream targets, but it is still partially uncovered. This study aimed to explore the molecular mechanisms of GC by comprehensive analysis of mRNAs and miRNA expression profiles. METHODS: The mRNA and miRNA expression profiles of GSE79973 and GSE67354 downloaded from Gene Expression Omnibus were used to analyze the differentially expressed genes (DEGs) and DE-miRNAs among GC tissues and normal tissues. Then, targets genes of DE-miRNAs were predicted and the DE-miRNA-DEG regulatory network was constructed. Next, function enrichment analysis of the overlapped genes between the predicted DE-miRNAs targets and DEGs was performed and a protein-protein interactions network of overlapped genes was constructed. Finally, RT-PCR analysis was performed to detect the expression levels of several key DEGs and DE-miRNAs. RESULTS: A set of 703 upregulated and 600 downregulated DEGs, as well as 8 upregulated DE-miRNAs and 27 downregulated DE-miRNAs were identified in GC tissue. hsa-miR-193b-3p and hsa-miR-148a-3p, which targeted most DEGs, were highlighted in the DE-miRNA-DEG regulatory network, as well as hsa-miR-1179, which targeted KNL1, was newly predicted to be associated with GC. In addition, NCAPG, which is targeted by miR-193b-3p, and KNL1, which is targeted by hsa-miR-1179, had higher degrees in the PPI network. RT-qPCR results showed that hsa-miR-148a-3p, hsa-miR-193b-3p, and hsa-miR-1179 were downregulated, and NCAPG and KNL1 were upregulated in GC tissues; this is consistent with our bioinformatics-predicted results. CONCLUSIONS: The downregulation of miR-193b-3p might contribute to GC cell proliferation by mediating the upregulation of NCAPG; as additionally, the downregulation of miR-193b-3p might contribute to the mitotic nuclear division of GC cells by mediating the upregulation of KNL1.


Asunto(s)
Proteínas de Ciclo Celular/metabolismo , Regulación Neoplásica de la Expresión Génica/genética , MicroARNs/metabolismo , Neoplasias Gástricas/metabolismo , Regulación hacia Arriba/genética , Biomarcadores de Tumor/genética , Proteínas de Ciclo Celular/genética , Progresión de la Enfermedad , Perfilación de la Expresión Génica , Humanos , Proteínas Asociadas a Microtúbulos/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/genética
3.
Biol. Res ; 51: 44, 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-983945

RESUMEN

BACKGROUND: Emerging evidence indicate that miRNAs play an important role on gastric cancer (GC) progression via regulating several downstream targets, but it is still partially uncovered. This study aimed to explore the molecular mechanisms of GC by comprehensive analysis of mRNAs and miRNA expression profiles. METHODS: The mRNA and miRNA expression profiles of GSE79973 and GSE67354 downloaded from Gene Expression Omnibus were used to analyze the differentially expressed genes (DEGs) and DE-miRNAs among GC tissues and normal tissues. Then, targets genes of DE-miRNAs were predicted and the DE-miRNA-DEG regulatory network was constructed. Next, function enrichment analysis of the overlapped genes between the predicted DE-miRNAs targets and DEGs was performed and a protein-protein interactions network of overlapped genes was constructed. Finally, RT-PCR analysis was performed to detect the expression levels of several key DEGs and DE-miRNAs. RESULTS: A set of 703 upregulated and 600 downregulated DEGs, as well as 8 upregulated DE-miRNAs and 27 downregulated DE-miRNAs were identified in GC tissue. hsa-miR-193b-3p and hsa-miR-148a-3p, which targeted most DEGs, were highlighted in the DE-miRNA-DEG regulatory network, as well as hsa-miR-1179, which targeted KNL1, was newly predicted to be associated with GC. In addition, NCAPG, which is targeted by miR-193b-3p, and KNL1, which is targeted by hsa-miR-1179, had higher degrees in the PPI network. RT-qPCR results showed that hsa-miR-148a-3p, hsa-miR-193b-3p, and hsa-miR-1179 were downregulated, and NCAPG and KNL1 were upregulated in GC tissues; this is consistent with our bioinformatics-predicted results. CONCLUSIONS: The downregulation of miR-193b-3p might contribute to GC cell proliferation by mediating the upregulation of NCAPG; as additionally, the downregulation of miR-193b-3p might contribute to the mitotic nuclear division of GC cells by mediating the upregulation of KNL1.


Asunto(s)
Humanos , Neoplasias Gástricas/metabolismo , Regulación Neoplásica de la Expresión Génica/genética , Regulación hacia Arriba/genética , Proteínas de Ciclo Celular/metabolismo , MicroARNs/metabolismo , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/genética , Biomarcadores de Tumor/genética , Progresión de la Enfermedad , Proteínas de Ciclo Celular/genética , Perfilación de la Expresión Génica , Reacción en Cadena en Tiempo Real de la Polimerasa , Proteínas Asociadas a Microtúbulos/metabolismo
4.
Rev. panam. salud pública ; 38(1): 73-81, jul. 2015. ilus, tab
Artículo en Inglés | LILACS | ID: lil-761800

RESUMEN

OBJECTIVE: To examine the usefulness of "spot" urine iodine concentrations (UICs) in predicting 24-hour urine iodine excretion (UIE) for estimating average population iodine intake. METHODS: An electronic literature search was conducted for articles published through 19 May 2013 in MEDLINE (from 1950), EMBASE (from 1980), and the Cochrane Library (from 1993) using the terms "urinary excretion (timed or spot or random) and (24 h or 24 hour), iodine (iodine deficiency), iodine (intake)," and "urine (timed, spot, random, 24-hour)." Full-text articles about studies that examined > 40 healthy human subjects and measured UIE using the 24-hour urine collection method and UIC and/or UIE using one alternative method (spot (random), timed, and "overnight" (first morning urine), fasting or not fasting) were selected and reviewed. RESULTS: The review included data from 1 434 participants across the six studies that met the inclusion criteria. The main statistical methods for comparing data from the 24-hour urine collections with the values obtained from the alternative method(s) were either regression (β) or correlation (r) coefficients and concordance analysis through Bland-Altman plots. The urine samples collected using the alternative methods were subject to greater intra-individual and inter-individual variability than the 24-hour urine collections. There was a wide range in coefficient values for the comparisons between 24-hour URE measured in 24-hour urine collection and 24-hour UIE estimated using the alternative sampling methods. No alternative sampling method (spot, timed, or "overnight") was appropriate for estimating 24-hour UIE. CONCLUSIONS: The results of this systematic review suggest current data on UICs as a means of predicting 24-hour UIE for estimating population sodium intake are inadequate and highlight the need for further methodological investigations.


OBJETIVO: Analizar la utilidad de la concentraciones urinarias de yodo en una muestra puntual de orina como predicción de la excreción urinaria de yodo de 24 horas para calcular la ingesta promedio de yodo en la población. MÉTODOS: Se realizó una búsqueda de bibliografía electrónica de artículos publicados hasta el 19 de mayo del 2013 en MEDLINE (desde 1950), EMBASE (desde 1980) y la Biblioteca Cochrane (desde 1993) que utilizaran los términos "urinary excretion (timed or spot or random) y (24 h or 24 hour)", "iodine (iodine deficiency)", "iodine (intake)", y "urine (timed, spot, random, 24-hour)" ("excreción urinaria [programada o puntual o aleatoria] y [24 h o 24 horas]", "yodo [carencia de yodo]", "yodo [ingesta]", y "orina [programada, puntual, aleatoria, 24 horas]"). Se seleccionaron y analizaron artículos de texto completo acerca de estudios que hubieran examinado como mínimo a 40 personas sanas y medido la excreción urinaria de yodo mediante la recolección de orina de 24 horas, y la concentración urinaria de yodo o la excreción urinaria de yodo mediante un método alternativo (recolección puntual [aleatoria], programada y "de toda la noche" [primera orina de la mañana], en ayunas o no). RESULTADOS: La revisión incluyó datos de 1 434 participantes de los seis estudios que reunieron los criterios de inclusión. Los principales métodos estadísticos utilizados para comparar los datos de las recolecciones de orina de 24 horas con los valores obtenidos a partir de los métodos alternativos fueron los coeficientes de regresión (β) o correlación (r) y los análisis de concordancia mediante el gráfico de Bland-Altman. Las muestras de orina recolectadas mediante métodos alternativos presentaron una mayor variabilidad interpersonal y para una misma persona que las recolecciones de orina de 24 horas. Se observó una amplia gama de valores de los coeficientes en las comparaciones entre la excreción urinaria de yodo de 24 horas medida mediante la recolección de orina de 24 horas y la excreción urinaria de yodo de 24 horas calculada mediante métodos de muestreo alternativos. Ningún método de muestreo alternativo (puntual, programado o "de toda la noche") resultó apropiado para calcular la excreción urinaria de yodo de 24 horas. CONCLUSIONES: Los resultados de esta revisión sistemática indican que los datos actuales en cuanto a la concentración urinaria de yodo como factor predictivo de la excreción urinaria de yodo de 24 horas para calcular la ingesta de yodo en la población son inadecuados y subrayan la necesidad de nuevas investigaciones metodológicas.


Asunto(s)
Salud Poblacional , Yodo/análisis , Yodo/orina
5.
Rev Panam Salud Publica ; 38(1),jul. 2015
Artículo en Inglés | PAHO-IRIS | ID: phr-10011

RESUMEN

Objective. To examine the usefulness of ”spot” urine iodine concentrations (UICs) in predicting 24-hour urine iodine excretion (UIE) for estimating average population iodine intake. Methods. An electronic literature search was conducted for articles published through 19 May 2013 in MEDLINE (from 1950), EMBASE (from 1980), and the Cochrane Library (from 1993) using the terms “urinary excretion (timed or spot or random) and (24 h or 24 hour),” “iodine (iodine deficiency),” “iodine (intake),” and “urine (timed, spot, random, 24-hour).” Full-text articles about studies that examined ≥ 40 healthy human subjects and measured UIE using the 24-hour urine collection method and UIC and/or UIE using one alternative method (spot (random), timed, and “overnight” (first morning urine), fasting or not fasting) were selected and reviewed. Results. The review included data from 1 434 participants across the six studies that met the inclusion criteria. The main statistical methods for comparing data from the 24-hour urine collections with the values obtained from the alternative method(s) were either regression (β) or correlation (r) coefficients and concordance analysis through Bland–Altman plots. The urine samples collected using the alternative methods were subject to greater intra-individual and inter-individual variability than the 24-hour urine collections. There was a wide range in coefficient values for the comparisons between 24-hour URE measured in 24-hour urine collection and 24-hour UIE estimated using the alternative sampling methods. No alternative sampling method (spot, timed, or “overnight”) was appropriate for estimating 24-hour UIE. Conclusions. The results of this systematic review suggest current data on UICs as a means of predicting 24-hour UIE for estimating population sodium intake are inadequate and highlight the need for further methodological investigations.


Objetivo. Analizar la utilidad de la concentraciones urinarias de yodo en una muestra puntual de orina como predicción de la excreción urinaria de yodo de 24 horas para calcular la ingesta promedio de yodo en la población. Métodos. Se realizó una búsqueda de bibliografía electrónica de artículos publicados hasta el 19 de mayo del 2013 en MEDLINE (desde 1950), EMBASE (desde 1980) y la Biblioteca Cochrane (desde 1993) que utilizaran los términos “urinary excretion (timed or spot or random) y (24 h or 24 hour)”, “iodine (iodine deficiency)”, “iodine (intake)”, y “urine (timed, spot, random, 24-hour)” (“excreción urinaria [programada o puntual o aleatoria] y [24 h o 24 horas]”, “yodo [carencia de yodo]”, “yodo [ingesta]”, y “orina [programada, puntual, aleatoria, 24 horas]”). Se seleccionaron y analizaron artículos de texto completo acerca de estudios que hubieran examinado como mínimo a 40 personas sanas y medido la excreción urinaria de yodo mediante la recolección de orina de 24 horas, y la concentración urinaria de yodo o la excreción urinaria de yodo mediante un método alternativo (recolección puntual [aleatoria], programada y “de toda la noche” [primera orina de la mañana], en ayunas o no). Resultados. La revisión incluyó datos de 1 434 participantes de los seis estudios que reunieron los criterios de inclusión. Los principales métodos estadísticos utilizados para comparar los datos de las recolecciones de orina de 24 horas con los valores obtenidos a partir de los métodos alternativos fueron los coeficientes de regresión (β) o correlación (r) y los análisis de concordancia mediante el gráfico de Bland-Altman. Las muestras de orina recolectadas mediante métodos alternativos presentaron una mayor variabilidad interpersonal y para una misma persona que las recolecciones de orina de 24 horas. Se observó una amplia gama de valores de los coeficientes en las comparaciones entre la excreción urinaria de yodo de 24 horas medida mediante la recolección de orina de 24 horas y la excreción urinaria de yodo de 24 horas calculada mediante métodos de muestreo alternativos. Ningún método de muestreo alternativo (puntual, programado o “de toda la noche”) resultó apropiado para calcular la excreción urinaria de yodo de 24 horas. Conclusiones. Los resultados de esta revisión sistemática indican que los datos actuales en cuanto a la concentración urinaria de yodo como factor predictivo de la excreción urinaria de yodo de 24 horas para calcular la ingesta de yodo en la población son inadecuados y subrayan la necesidad de nuevas investigaciones metodológicas.


Asunto(s)
Yodo , Orina , Toma de Muestras de Orina , Población , Yodo , Orina , Toma de Muestras de Orina , Población
8.
Rev. panam. salud pública ; 32(4): 307-315, Oct. 2012. ilus
Artículo en Inglés, Portugués | LILACS | ID: lil-659978

RESUMEN

Objective. To examine the usefulness of urine sodium (Na) excretion in spot or timed urine samples to estimate population dietary Na intake relative to the gold standard of 24-hour (h) urinary Na. Methods. An electronic literature search was conducted of MEDLINE (from 1950) and EMBASE (from 1980) as well as the Cochrane Library using the terms “sodium,” “salt,” and “urine.” Full publications of studies that examined 30 or more healthy human subjects with both urinary Na excretion in 24-h urine and one alternative method (spot, overnight, timed) were examined. Results. The review included 1 380 130 participants in 20 studies. The main statistical method for comparing 24-h urine collections with alternative methods was the use of a correlation coefficient. Spot, timed, and overnight urine samples were subject to greater intraindividual and interindividual variability than 24-h urine collections. There was a wide range of correlation coefficients between 24-h urine Na and other methods. Some values were high, suggesting usefulness (up to r = 0.94), while some were low (down to r = 0.17), suggesting a lack of usefulness. The best alternative to collecting 24-h urine (overnight, timed, or spot) was not clear, nor was the biological basis for the variability between 24-h and alternative methods. Conclusions. There is great interest in replacing 24-h urine Na with easier methods to assess dietary Na. However, whether alternative methods are reliable remains uncertain. More research, including the use of an appropriate study design and statistical testing, is required to determine the usefulness of alternative methods.


Objetivo. Analizar la utilidad de la medicion de la excrecion urinaria de sodio a partir de la recoleccion puntual o cronometrada de muestras de orina para calcular la ingesta de sodio alimentario en la poblacion, en relacion con la prueba de referencia que mide la excrecion de sodio en orina de 24 horas. Métodos. Se realizo una busqueda de bibliografia electronica en MEDLINE (desde 1950) y EMBASE (desde 1980), asi como en la Biblioteca Cochrane, empleando los terminos “sodium”, “salt” y “urine” (sodio, sal y orina). Se examinaron las publicaciones completas de los estudios que incluian 30 o mas sujetos humanos sanos en los que se hubiera determinado la excrecion de sodio mediante la recoleccion de orina de 24 horas o un metodo alternativo (recoleccion puntual, de toda la noche, cronometrada). Resultados. La revision incluyo a 1 380 130 participantes de 20 estudios. El principal metodo estadistico adoptado para comparar las recolecciones de orina de 24 horas con los metodos alternativos fue el uso de un coeficiente de correlacion (r). Las muestras de orina recolectadas de forma puntual, cronometrada y de toda la noche estaban sujetas a mayor variabilidad intra e interindividual que las recolecciones de orina de 24 horas. Se obtuvo una amplia gama de coeficientes de correlacion entre las determinaciones de sodio en orina de 24 horas y mediante los otros metodos. Algunos valores fueron elevados, lo que indica su utilidad (r de hasta 0,94), mientras que otros fueron bajos (r por debajo de 0,17), lo que indica su falta de utilidad. La mejor alternativa a la obtencion de orina de 24 horas (de toda la noche, cronometrada, o puntual) no resulto evidente, ni tampoco la base biologica de la variabilidad entre el metodo de 24 horas y los alternativos. Conclusiones. Hay mucho interes en remplazar la determinacion de sodio en orina de 24 horas por otros metodos mas faciles de evaluacion del sodio alimentario. Sin embargo, sigue habiendo incertidumbre sobre la fiabilidad de los metodos alternativos. Es preciso ampliar la investigacion, incluido el uso de un diseno de estudio y pruebas estadisticas apropiados, para determinar la utilidad de los metodos alternativos.


Asunto(s)
Humanos , Cloruro de Sodio Dietético/administración & dosificación , Cloruro de Sodio Dietético/orina , Factores de Tiempo , Toma de Muestras de Orina/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA